X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.prnewswire.com/news-releases/heron-therapeutics-announces-partnership-with-crosslink-life-sciences-to-expand-promotional-effort-for-zynrelef-the-first-and-only-non-opioid-dual-acting-local-anesthetic-for-post-operative-pain-302027807.html
https://www.prnewswire.com/news-releases/heron-therapeutics-announces-filing-of-an-efficacy-supplement-for-zynrelef-and-provision-in-newly-passed-congressional-bill-anticipated-to-provide-separate-reimbursement-outside-of-the-packaged-surgical-payment-for-zynrelef-301710904.html
https://www.prnewswire.com/news-releases/innocoll-and-durect-announce-us-launch-of-posimir-301632764.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-24-2022-1661335123.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-bupivacaine-liposome-1655269911.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-aprepitant-azilsartan-bupivacaine-cladribine-elrombopag-fosnetupitant-fostamatinib-ivacaftor-and-sodium-thiosulfate-1655270821.pdf
https://investor.pacira.com/news-releases/news-release-details/pacira-biosciences-reports-preliminary-revenues-1574-1584
https://www.prnewswire.com/news-releases/heron-therapeutics-announces-fda-approval-of-a-significant-indication-expansion-for-zynrelef-301440851.html
https://www.fiercepharma.com/pharma/pacira-boosts-non-opioid-pain-portfolio-via-450m-flexion-buy-more-cvr-payments-to-come
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-exparel-22496-bupivacaine-liposome-226mg20ml-injectable-suspension-1633682680.pdf
https://www.globenewswire.com/news-release/2021/06/22/2250938/0/en/Pacira-Announces-EXPAREL-Distribution-Agreement-with-Eurofarma-in-Latin-America.html#:~:text=Pacira%20Announces%20EXPAREL%20Distribution%20Agreement%20with%20Eurofarma%20in%20Latin%20America&text=PARSIPPANY%2C%20N.J.%2C%20June%2022%2C,)%20%2D%2D%20Pacira%20BioSciences%2C%20Inc.&text=%E2%80%9CThis%20new%20partnership%20reflects%20the,on%20opioids%20in%20Latin%20America.
https://www.fiercepharma.com/pharma/heron-s-newly-minted-opioid-alternative-for-post-surgical-pain-headed-for-blockbuster-land
https://investor.pacira.com/news-releases/news-release-details/pacira-biosciences-seeks-court-injunction-protect-clinical
https://www.biospace.com/article/releases/innocoll-biotherapeutics-plc-announces-first-patients-in-phase-3-clinical-trials-for-label-expansion-of-xaracoll-bupivacaine-hydrochloride-implant/
https://www.biospace.com/article/releases/durect-corporation-announces-u-s-fda-approval-of-posimir-for-post-surgical-pain-reduction-for-up-to-72-hours-following-arthroscopic-subacromial-decompression/?s=74#:~:text=CUPERTINO%2C%20Calif.%2C%20Feb.,direct%20arthroscopic%20visualization%20to%20produce
https://investor.pacira.com/news-releases/news-release-details/pacira-receives-european-commission-approval-exparelr
https://www.prnewswire.com/news-releases/innocoll-announces-commercial-launch-of-xaracoll-bupivacaine-hci-implant-a-non-opioid-drug-device-treatment-option-for-acute-postsurgical-pain-relief-for-up-to-24-hours-following-open-inguinal-hernia-repair-in-adults-301163002.html
https://www.ema.europa.eu/documents/product-information/zynrelef-epar-product-information_en.pdf
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-14-17-september-2020
https://www.globenewswire.com/news-release/2020/09/18/2095820/0/en/Pacira-Receives-Positive-CHMP-Opinion-for-EXPAREL-bupivacaine-liposome-injectable-suspension-for-the-Treatment-of-Postsurgical-Pain.html
https://www.pharmtech.com/view/ema-recommends-seven-medicines-for-approval
https://www.globenewswire.com/news-release/2020/07/28/2069074/0/en/Pacira-BioSciences-Announces-Settlement-of-Government-Investigation.html#:~:text=Pacira%20to%20Pay%20%243.5%20Million,with%20No%20Admission%20of%20Wrongdoing&text=PARSIPPANY%2C%20N.J.%2C%20July%2028%2C,)%20%2D%2D%20Pacira%20BioSciences%2C%20Inc.&text=Under%20the%20various%20settlement%20agreements,aggregate%20of%20approximately%20%243.5%20million.
https://www.raps.org/news-and-articles/news-articles/2020/7/ema-thumbs-up-for-11-down-for-2-new-medicines
https://www.prnewswire.com/news-releases/heron-therapeutics-announces-publication-of-results-from-study-209-a-phase-2b-study-of-htx-011-in-patients-undergoing-total-knee-arthroplasty-301070514.html
https://www.pharmacompass.com/pdf/news/pharmedium-services-issues-voluntary-nationwide-recall-of-certain-lots-of-compounded-sterile-products-1587014091.pdf
https://endpts.com/herons-groundhog-day-vifor-forms-jv-with-fresenius-kabi-in-china/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-11-2019-1576044384.pdf
https://www.pharmacompass.com/pdf/news/KRS-Global-Biotechnology-Issues-Voluntary-Nationwide-Recall-of-All-Human-and-Animal-Sterile-Drug-Products-1568424609.pdf
https://www.prnewswire.com/news-releases/aratana-therapeutics-granted-fda-approval-of-nocita-bupivacaine-liposome-injectable-suspension-10-ml-vial-300865670.html
https://www.biospace.com/article/releases/aratana-therapeutics-to-be-acquired-by-elanco-animal-health/?s=79
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-April-24-2019-1556080066.pdf
https://www.biospace.com/article/releases/durect-announces-plans-to-submit-to-fda-a-full-response-to-the-posimir-complete-response-letter/
https://www.raps.org/news-and-articles/news-articles/2018/11/fda-warns-against-using-implanted-pumps-with-unapp?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2014%20November
https://www.fiercebiotech.com/liquidia-files-for-ipo-to-challenge-united-therapeutics-pah
https://www.prnewswire.com/news-releases/noblestitch-el-continues-expansion-through-europe-with-sales-launch-in-the-netherlands-300658554.html
https://www.prnewswire.com/news-releases/durect-announces-amendment-to-licensing-agreement-with-sandoz-related-to-posimir-saber-bupivacaine-300645154.html
https://www.fiercebiotech.com/biotech/novartis-durect-renegotiate-293m-painkiller-deal-after-phase-3-failure
https://www.prnewswire.com/news-releases/durect-announces-fda-advisory-committee-meeting-for-remoxy-er-300616364.html
https://pharmaphorum.com/news/fda-advisers-reject-new-use-pacira-nerve-block/
https://www.pharmacompass.com/pdf/news/SCA-Pharmaceuticals-Issues-Voluntary-Nationwide-Recall-of-Specific-Products-1508760244.pdf
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-August-2-2017-1501649040.pdf
https://globenewswire.com/news-release/2016/12/29/902225/0/en/Innocoll-Receives-Refusal-to-File-Letter-from-U-S-FDA-for-XARACOLL-bupivacaine-HCl-collagen-matrix-implants-New-Drug-Application.html
http://www.prnewswire.com/news-releases/aratana-therapeutics-announces-launch-of-nocita-bupivacaine-liposome-injectable-suspension-300339358.html
http://www.pmlive.com/pharma_news/fertility_drugs_drive_healthcare_growth_at_merck_kgaa_1090408
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/claris-life-gets-usfda-nod-for-generic-anesthetic-injection/articleshow/53395191.cms
http://www.fiercepharma.com/story/amarin-and-fda-near-settlement-label-free-speech-ask-court-30-more-days/2016-02-19
Market Place
Share 
